Suppr超能文献

伴有肿瘤血栓的肾细胞癌:普通泌尿外科医生相关解剖及手术技术综述

Renal cell carcinoma with tumor thrombus: A review of relevant anatomy and surgical techniques for the general urologist.

作者信息

Almatari Abraham L, Sathe Aditya, Wideman Lauren, Dewan Christian A, Vaughan Joseph P, Bennie Ian C, Buscarini Maurizio

机构信息

Department of Urology, The University of Tennessee Health Science Center, Memphis, TN.

Department of Urology, The University of Tennessee Health Science Center, Memphis, TN.

出版信息

Urol Oncol. 2023 Apr;41(4):153-165. doi: 10.1016/j.urolonc.2022.11.021. Epub 2023 Feb 17.

Abstract

Renal cell carcinoma (RCC) is estimated to account for 4.1% of all new cancer diagnoses and 2.4% of all cancer deaths in 2020 according to the National Cancer Institute SEER database. This will likely total 73,000 new cases and 15,000 deaths. RCC is one of the most lethal of the common cancers urologists will encounter with a 5-year relative survival of 75.2%. Renal cell carcinoma is one of a small subset of malignancies that are associated with tumor thrombus formation, which is tumor extension into a blood vessel. An estimated 4% to 10% of patients with RCC will have some degree of tumor thrombus extending into the renal vein or inferior vena cava at the time of diagnosis. Tumor thrombi change the staging of RCC and therefore are an important part of initial patient workup. It is known that such tumors are more aggressive with higher Fuhrman grades, N+ or M+ at time of surgery and have higher probability of recurrence with lower cancer-specific survival. Aggressive surgical intervention with radical nephrectomy and thrombectomy can be performed with survival benefits. Classifying the level of the tumor thrombus becomes vitally important in surgical planning as it will dictate the surgical approach. Level 0 thrombi may be amenable to simple renal vein ligation while level 4 can require thoracotomy and possible open-heart surgery with coordination of many surgical teams. Here we will review the anatomy associated with each level of tumor thrombus and attempt to construct an outline for surgical techniques that may be used. We aim to give a concise overview so that general urologists may use it to understand these potentially complicated cases.

摘要

根据美国国立癌症研究所监测、流行病学和最终结果(SEER)数据库,2020年肾细胞癌(RCC)估计占所有新发癌症诊断病例的4.1%,占所有癌症死亡病例的2.4%。这可能总计有73000例新发病例和15000例死亡。肾细胞癌是泌尿外科医生会遇到的最致命的常见癌症之一,其5年相对生存率为75.2%。肾细胞癌是与肿瘤血栓形成相关的一小部分恶性肿瘤之一,肿瘤血栓形成即肿瘤延伸至血管。估计4%至10%的肾细胞癌患者在诊断时会有一定程度的肿瘤血栓延伸至肾静脉或下腔静脉。肿瘤血栓会改变肾细胞癌的分期,因此是患者初始检查的重要组成部分。已知这类肿瘤侵袭性更强,手术时Fuhrman分级更高、有淋巴结转移(N+)或远处转移(M+),复发概率更高,癌症特异性生存率更低。采用根治性肾切除术和血栓切除术进行积极的手术干预可带来生存获益。在手术规划中,对肿瘤血栓水平进行分类至关重要,因为这将决定手术方式。0级血栓可能适合单纯肾静脉结扎,而4级血栓可能需要开胸手术,甚至可能需要心脏直视手术,并需要多个手术团队协作。在此,我们将回顾与各肿瘤血栓水平相关的解剖结构,并尝试构建一份可能使用的手术技术概述。我们旨在提供一个简明的综述,以便普通泌尿外科医生能够用以了解这些潜在的复杂病例。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验